Navigation Links
Kidney Removal May Be Ill-Advised for Some Elderly
Date:5/10/2010

With localized cancer, more conservative treatment may be warranted, study finds

MONDAY, May 10 (HealthDay News) -- Removing a kidney does not seem to extend the life of elderly people with kidney cancer that has not spread, a new study finds.

Instead, it suggests, people with such cancer should undergo more conservative treatments that preserve the non-cancerous parts of their kidneys.

Kidney cancer cases have increased over the past 10 years, especially among older people, and doctors are trying to figure out the best way to treat what they call localized cancer in this age group.

In the new study, Dr. Steve Campbell of the Cleveland Clinic and his colleagues examined the medical records of 537 people who were at least 75 years old and had localized kidney tumors.

About 20 percent of them were simply observed, 53 percent had surgery that spared their kidney and 27 percent had their kidney removed. In the next four years, 28 percent of the overall group died, but just 4 percent of the deaths were attributable to progression of their cancer.

The type of treatment did not affect the risk for dying, the researchers found. Rather, additional medical problems were found to have raised that risk. And, people who had a kidney removed had increased problems with their remaining kidney, the study found.

The findings were published online May 10 in Cancer.

More information

For more about kidney cancer, visit the American Urological Association.



-- Randy Dotinga



SOURCE: American Cancer Society, news release, May 10, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Kidney removal does not prolong the lives of elderly patients with localized kidney cancer
2. Study Disputes Link Between Milk and Kidney Cancer
3. Anemia Drugs Hold Dangers for Kidney Patients
4. Transplant drug 2-year study outcomes show superior kidney function
5. Why Spouses of Dialysis Patients Get Kidney Disease Too
6. Cancer risk for kidney transplant
7. Cancer Risk After Kidney Transplant Unaffected by Type of Drug Treatment
8. High-Dose Vitamin B Risky for Diabetics With Kidney Disease
9. Anemia Harder to Treat in Black Children With Kidney Disease
10. Anemia tougher to tackle in black children with kidney disease
11. Routine screening for pediatric chronic kidney disease is not effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... ... and sexual objectification, according to Georgia State University researchers. , In ... in the fifth, sixth and seventh grades shared their experiences with strained ...
(Date:5/23/2016)... ... May 23, 2016 , ... Cosmetic Town, an ... about cosmetic procedures, began updating their library of over 300 encyclopedic medical articles. ... articles in order to feature the latest breakthroughs in plastic surgery procedures since ...
(Date:5/23/2016)... WASHINGTON, D.C. (PRWEB) , ... May 23, 2016 , ... ... Phyllis Greenberger, MSW, has decided to move on from that role. , “No one ... years as did Phyllis Greenberger,” said SWHR Founder Florence Haseltine, MD, PhD. “We offer ...
(Date:5/23/2016)... ... 2016 , ... In Pursuit of Balance (IPOB) co-founders Jasmine Hirsch and Rajat ... the end of 2016. , “We created IPOB to change the dialogue around ... back on what we have achieved, we’re gratified by the response of wine producers, ...
(Date:5/23/2016)... ... May 23, 2016 , ... Four Circles Recovery Center, a ... is proud to announce the launch of its new extended care program, Fifth Circle. ... treatment at Four Circles or another primary treatment program, Fifth Circle is designed to ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... SAN FRANCISCO, Calif. , May 19, 2016 /PRNewswire/ ... a biopharmaceutical company developing novel therapeutics for the treatment ... announced that new GBT440 data will be presented in ... 21 st Congress in Copenhagen ... ongoing Phase 1/2 GBT440-001 study in sickle cell disease ...
(Date:5/19/2016)... 2016 BioLineRx Ltd. (NASDAQ/TASE: BLRX) ... treatment of multiple cancer and hematological indications, will be ... abstract titled " Clinical response in relapsed/refractory AML patients ... BL-8040, a potent CXCR4 antagonist; results of a Phase ... at the European Hematology Association 21st Congress, to be ...
(Date:5/19/2016)... CAMBRIDGE, Massachusetts , May 19, 2016 ... pharmaceuticals and diagnostics based on the gut microbiome, is pleased ... Cambridge, MA to support its operations ... office is located at Kendall Square, the heart of ... global hub for transforming scientific insights into new drugs. The ...
Breaking Medicine Technology: